American International Group, Inc. Astria Therapeutics, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$6.99 - $16.69 $56,772 - $135,556	8,122 Added 49.39%	24,565 $345,000
Q4 2023 Feb 13, 2024	BUY	$4.42 - $8.06 $16,327 - $29,773	3,694 Added 28.97%	16,443 $126,000
Q3 2023 Nov 13, 2023	BUY	$6.89 - $9.86 $3,121 - $4,466	453 Added 3.68%	12,749 $95,000
Q2 2023 Aug 04, 2023	BUY	$8.33 - $13.72 $102,425 - $168,701	12,296 New	12,296 $102,000

107

48.6M

48K

9.3K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $135M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.